Pharmacologic Ascorbic Acid as Early Therapy for Hospitalized Patients with COVID-19: A Randomized Clinical Trial

Despite the widespread availability of effective vaccines, new cases of infection with severe acute respiratory syndrome coronavirus-2, the cause of coronavirus disease 2019 (COVID-19), remain a concern in the settings of vaccine hesitancy and vaccine breakthrough. In this randomized, controlled, ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Coppock, Dagan, Violet, Pierre-Christian, Vasquez, Gustavo, Belden, Katherine, Foster, Michael, Mullin, Bret, Magee, Devon, Mikell, Isabelle, Shah, Lokesh, Powers, Victoria, Curcio, Brian, Monti, Daniel, Levine, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954118/
https://www.ncbi.nlm.nih.gov/pubmed/35330204
http://dx.doi.org/10.3390/life12030453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954118/
https://www.ncbi.nlm.nih.gov/pubmed/35330204
http://dx.doi.org/10.3390/life12030453

Ejemplares similares